Health & TechA trial showed an AI risk score sped up autoimmune diagnoses
In a Vanderbilt randomized trial of nearly 2,000 analyzed patients with positive ANA tests, flagging high-risk patients for fast-track rheumatology referral cut the median time to diagnosis from 138 days to 43. The study is in NEJM AI and was supported by the NIH.
Verified · Vanderbilt Health News
